Funder: National Institutes of Health
Due Dates: June 18, 2025 (Letter of Intent) | July 18, 2025 (Application)
Funding Amounts: Up to $500,000 direct costs/year for up to 5 years (max $2.5M direct costs); up to 6 awards expected
Summary: Supports pioneering, high-impact basic or preclinical research (no clinical trials) in diabetes, endocrinology, metabolic, digestive, and nutritional diseases.
Key Information: Only single PD/PI applications allowed; research must be a new direction, distinct from ongoing work; clinical trials are not permitted.